Your browser doesn't support javascript.
loading
A Phase I/II Open-Label Study of Molibresib for the Treatment of Relapsed/Refractory Hematologic Malignancies.
Dawson, Mark A; Borthakur, Gautam; Huntly, Brian J P; Karadimitris, Anastasios; Alegre, Adrian; Chaidos, Aristeidis; Vogl, Dan T; Pollyea, Daniel A; Davies, Faith E; Morgan, Gareth J; Glass, Jacob L; Kamdar, Manali; Mateos, Maria-Victoria; Tovar, Natalia; Yeh, Paul; Delgado, Regina García; Basheer, Faisal; Marando, Ludovica; Gallipoli, Paolo; Wyce, Anastasia; Krishnatry, Anu Shilpa; Barbash, Olena; Bakirtzi, Evi; Ferron-Brady, Geraldine; Karpinich, Natalie O; McCabe, Michael T; Foley, Shawn W; Horner, Thierry; Dhar, Arindam; Kremer, Brandon E; Dickinson, Michael.
Afiliação
  • Dawson MA; Department of Clinical Haematology, Peter MacCallum Cancer Centre, Royal Melbourne Hospital, Melbourne, Victoria, Australia.
  • Borthakur G; The Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia.
  • Huntly BJP; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Karadimitris A; University of Cambridge, Cambridge, United Kingdom.
  • Alegre A; Hugh and Josseline Langmuir Centre for Myeloma Research, Centre for Haematology, Department of Immunology and Inflammation, Imperial College London and Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom.
  • Chaidos A; Hospital Universitario de La Princesa and Quironsalud, Madrid, Spain.
  • Vogl DT; Hugh and Josseline Langmuir Centre for Myeloma Research, Centre for Haematology, Department of Immunology and Inflammation, Imperial College London and Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom.
  • Pollyea DA; Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Davies FE; University of Colorado School of Medicine, Aurora, Colorado.
  • Morgan GJ; Perlmutter Cancer Center, NYU Langone Medical Center, New York, New York.
  • Glass JL; Perlmutter Cancer Center, NYU Langone Medical Center, New York, New York.
  • Kamdar M; Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Mateos MV; University of Colorado School of Medicine, Aurora, Colorado.
  • Tovar N; Hospital Universitario de Salamanca, IBSAL, CIBERONC, Salamanca, Spain.
  • Yeh P; Hospital Clínic, University of Barcelona, Barcelona, Spain.
  • Delgado RG; Department of Clinical Haematology, Peter MacCallum Cancer Centre, Royal Melbourne Hospital, Melbourne, Victoria, Australia.
  • Basheer F; The Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia.
  • Marando L; Hospital Virgen de la Victoria, Málaga, Spain.
  • Gallipoli P; Addenbrooke's Hospital, Cambridge, United Kingdom.
  • Wyce A; University of Cambridge, Cambridge, United Kingdom.
  • Krishnatry AS; Addenbrooke's Hospital, Cambridge, United Kingdom.
  • Barbash O; GSK, Collegeville, Pennsylvania.
  • Bakirtzi E; GSK, Collegeville, Pennsylvania.
  • Ferron-Brady G; GSK, Collegeville, Pennsylvania.
  • Karpinich NO; GSK, Collegeville, Pennsylvania.
  • McCabe MT; GSK, Collegeville, Pennsylvania.
  • Foley SW; GSK, Collegeville, Pennsylvania.
  • Horner T; GSK, Collegeville, Pennsylvania.
  • Dhar A; GSK, Collegeville, Pennsylvania.
  • Kremer BE; GSK, Collegeville, Pennsylvania.
  • Dickinson M; GSK, Collegeville, Pennsylvania.
Clin Cancer Res ; 29(4): 711-722, 2023 02 16.
Article em En | MEDLINE | ID: mdl-36350312
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Trombocitopenia / Linfoma não Hodgkin / Leucemia Mieloide Aguda / Neoplasias Hematológicas Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Trombocitopenia / Linfoma não Hodgkin / Leucemia Mieloide Aguda / Neoplasias Hematológicas Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article